Sun Pharma Q1 net profit drops 2% YoY, Revenue up 11%; US sales at $471 mn Mankind Pharma IPO to open next week: Check price band, GMP, other details Sun Pharma Q1 profit may be weighed by weak US generic sales and Taro nos Pharma stocks rally on lower price erosion, hopes of US generic… Continue reading Fierce competition among new drug brands for share of India market